Multiplicom Receives $250K Grant to Develop Genetic Fetal Aneuploidy Test | GenomeWeb

NEW YORK (GenomeWeb News) – Belgian molecular diagnostics firm Multiplicom today said it has been awarded €200,000 ($250,000) to develop a blood-based non-invasive fetal aneuploidy test.

The grant from the Flemish agency for Innovation by Science and Technology will be used by Multiplicom to develop the test based on its Multiplex Amplification of Specific Targets for Resequencing workflow. The PCR-based test detects copy number variations in chromosomes 21, 18, 13, X and Y in fetal DNA isolated from the mother's blood.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.